Company intelligence / Profile preview

Gufic Biosciences

Mumbai, Maharashtra, Indiagufic.com ↗

Ownership: Private
Employees: ~1491
Development stage: Other

Overview

Gufic Biosciences has a broad commercial portfolio with over 100 registered products globally and more than 150 in the pipeline for registration across multiple countries. The company leads in lyophilized injectables in India and has significant penetration in critical care and fertility markets. It recently expanded into botulinum toxin manufacturing through a partnership with Prime Bio USA[6][8].

Therapeutic areas: GastroenterologyCardiovascularInfectious DiseasesEndocrinology
Modalities: Small moleculeBiologicMonoclonal antibody (for botulinum toxin)Hormone therapyHerbal formulation
Industry: Biotech

Partnerships

Prime Bio USA – partnership for manufacturing botulinum toxin API/formulationsOther contract manufacturing relationships with leading domestic/international pharma companies as CDMO partner.Key hospital chains as customers.

Beyond the preview

Go deeper on Gufic Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gufic Biosciences.

Explore the full profile